Anthropic submitted a key filing on Monday as it prepares for a much‑watched initial public offering, revealing new information about its financial performance and the challenges it faces. The company intends to list on Nasdaq under the ticker ANT, with a possible launch later in November, according to the Wall Street Journal. The prospectus does not disclose the amount it hopes to raise or the target market value; the New York Times reported in August that the firm was aiming for a valuation near $2 trillion and a capital raise exceeding $100 billion.
In the filing the AI firm described the rise of machine intelligence as “one of the seminal moments in human history,” adding that prospective shareholders should view their investment as a chance to join something larger than a simple transaction.
Financial data covering the first half of 2026 shows revenue climbing to more than $16 billion, up from roughly $4.5 billion a year earlier. Anthropic highlighted growth in its enterprise segment, noting that over 11,900 customers spent at least $100,000 in the past twelve months, more than 1,900 customers exceeded $1 million in spend, and about 250 customers spent $10 million or more.
Despite the revenue jump, the company remains unprofitable, posting a net loss of $80.7 billion for the first half of 2026, compared with a net loss of $13 billion in the same period a year earlier.
The prospectus also contains an extensive list of risk factors, warning that investing in the stock involves a high degree of risk. Among the concerns are the need for sufficient computing power, fierce competition from other AI labs, and the possibility that advanced AI systems could pose catastrophic or existential threats to humanity. The filing flags the risk that sophisticated AI could be misused by malicious actors to launch cyberattacks, create new biological weapons, or enable authoritarian regimes to increase surveillance. Anthropic also warned that it could lose control over the models it builds.
Government actions add another layer of uncertainty. The document cites the Trump administration’s decision to label the company a supply‑chain risk and notes that ongoing lawsuits could affect Anthropic’s ability to sell to government agencies or to customers that serve the U.S. government, potentially harming its business and financial condition.
In September, rival OpenAI, which had filed confidentially for an IPO earlier in the summer, announced it would not pursue a public listing this year, citing concerns about AI’s risks to humanity.
Anthropic was founded in 2021 by seven former OpenAI employees who reportedly grew skeptical of the lab’s ability to develop advanced AI safely. The company markets itself as safety‑focused; CEO Dario Amodei has repeatedly warned that AI could eliminate many jobs and act contrary to human interests.
The filings also outline Anthropic’s ambition to create advanced AI models that could accelerate scientific research, help cure diseases, and drive economic growth. The company wrote, “To build AI is to harness cognition itself, and anything so powerful can be used for ill as well as good.”
Anthropic did not immediately respond to WIRED’s request for comment. This story is developing; updates will follow.